Stock Fundamentals

Company Information

Company Name
Gossamer Bio Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US38341P1021
CIK: 0001728117
CUSIP: 38341P102
Currency: USD
Full Time Employees: 144
Phone: 858 684 1300
Fiscal Year End: December
IPO Date: Feb 08, 2019
Description:

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. The company was incorporated in 2015 and is headquartered in San Diego, California.

Address:

3115 Merryfield Row, San Diego, CA, United States, 92121

Directors & Officers

Name Title Year Born
Mr. Faheem Hasnain Co-Founder, CEO, President & Chairman 1958
Mr. Bryan Giraudo COO & CFO 1975
Dr. Richard Aranda M.D. Chief Medical Officer 1960
Mr. Christian Waage J.D. Executive Vice President of Technical Operations & Administration 1967
Mr. Jeff Boerneke General Counsel & Secretary NA
Ms. Jeanine Anthony Senior Vice President of Marketing NA
Ms. Deanna Weber Executive Vice President of Human Resources NA
Dr. Robert F. Roscigno Ph.D. Senior Vice President of Clinical Development of Pulmonary Vascular Disease 1966
Ms. Caryn L. Peterson Executive Vice President of Regulatory Affairs 1959
Mr. Matt Cravets Senior Vice President of Biometrics NA

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
NEA Management Company, LLC 18.09M Dec 31, 2025 7.82% $2.86 0.00%
Octagon Capital Advisors LP 13.92M Dec 31, 2025 6.01% $5.24 -18.38%
BlackRock Inc 13.85M Sep 30, 2025 5.98% $0.00 14.03%
Vanguard Group Inc 12.87M Dec 31, 2025 5.56% $0.00 7.19%
ARCH VENTURE CORP 8.06M Sep 30, 2025 3.48% $4.30 0.00%
Samsara BioCapital, LLC 7.22M Dec 31, 2025 3.12% $2.31 17.82%
Palo Alto Investors, LLC 5.46M Sep 30, 2025 2.36% $2.66 -4.79%
Siren, L.L.C. 5.21M Dec 31, 2025 2.25% $0.48 0.00%
683 Capital Management LLC 5.06M Sep 30, 2025 2.19% $0.70 -20.20%
Acadian Asset Management LLC 5.01M Sep 30, 2025 2.17% $0.02 0.00%
Hillhouse Capital Advisors, Ltd. 4.97M Sep 30, 2025 2.15% $0.32 0.00%
Geode Capital Management, LLC 4.69M Sep 30, 2025 2.03% $0.00 2.95%
FMR Inc 4.24M Dec 31, 2025 1.83% $0.00 3.73%
State Street Corp 3.88M Sep 30, 2025 1.68% $0.00 56.51%
Perceptive Advisors LLC 3.81M Sep 30, 2025 1.65% $0.29 0.00%
Millennium Management LLC 3.62M Sep 30, 2025 1.56% $0.00 629.34%
Two Sigma Investments LLC 3.40M Dec 31, 2025 1.47% $0.01 48.52%
Rock Springs Capital Management LP 3.27M Dec 31, 2025 1.41% $0.52 0.00%
Bank of America Corp 2.88M Sep 30, 2025 1.25% $0.00 4,196.22%
UBS Group AG 2.77M Sep 30, 2025 1.20% $0.00 785.73%

Shares Statistics

Shares Outstanding: 231.46M
Shares Float: 207.91M
% Insiders: 416.00%
% Institutions: 7,122.30%
Short % Float: 14.28%

🏆 Top 10 Institutional Holders

Rank Holder Name Shares Held % of Shares Change Date Reported
1 NEA Management Company, LLC 18.09M 7.82% ▲ 0.00% Dec 31, 2025
2 Octagon Capital Advisors LP 13.92M 6.01% ▼ 18.38% Dec 31, 2025
3 BlackRock Inc 13.85M 5.98% ▲ 14.03% Sep 30, 2025
4 Vanguard Group Inc 12.87M 5.56% ▲ 7.19% Dec 31, 2025
5 ARCH VENTURE CORP 8.06M 3.48% ▲ 0.00% Sep 30, 2025
6 Samsara BioCapital, LLC 7.22M 3.12% ▲ 17.82% Dec 31, 2025
7 Palo Alto Investors, LLC 5.46M 2.36% ▼ 4.79% Sep 30, 2025
8 Siren, L.L.C. 5.21M 2.25% ▲ 0.00% Dec 31, 2025
9 683 Capital Management LLC 5.06M 2.19% ▼ 20.20% Sep 30, 2025
10 Acadian Asset Management LLC 5.01M 2.17% ▲ 0.00% Sep 30, 2025

Valuation Metrics

Enterprise Value: $121.00M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $98.35M
EBITDA: $-153.22M
Book Value: $-0.36
Earnings/Share: $-0.69
Profit Margin: 0.00%
Operating Margin: -313.21%
ROA (TTM): -34.25%
ROE (TTM): -783.37%
Revenue (TTM): $44.05M
Revenue/Share (TTM): $0.19
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 40.20%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios (Yearly)

Financial Ratios (Quarterly)

Earnings History

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2024-12-31 6.88x 6.73x 0.91x -5.20x -4.97x
2023-12-31 5.94x 3.38x 0.80x -13.60x -1.31x
2022-12-31 5.32x 18.41x 0.96x -15.75x -1.05x
2021-12-31 8.32x 1.50x 0.65x -11.12x -0.87x
2020-12-31 13.51x 0.55x 0.41x -16.63x -0.78x
2019-12-31 11.09x 0.09x 0.17x N/A -0.17x
2018-12-31 11.37x 0.00x 1.50x -12,416.08x 0.00x
2017-12-31 0.35x -0.88x 16.42x -56.38x -0.91x
2016-12-31 0.42x -0.33x 3.05x N/A -0.48x

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Jun 24, 2024 Richard Aranda N/A Sale 1.91K $0.66 $1.26K
Jun 21, 2024 Faheem Hasnain N/A Purchase 372.00K $0.67 $249.24K
Mar 27, 2024 Bryan Giraudo N/A Sale 6.43K $1.16 $7.46K
Mar 27, 2024 Faheem Hasnain N/A Sale 23.17K $1.16 $26.88K
Mar 18, 2024 Richard Aranda N/A Sale 4.02K $1.33 $5.34K
Nov 13, 2023 Bryan Giraudo N/A Purchase 200.00K $0.56 $112.00K
Jun 22, 2023 Richard Aranda N/A Sale 1.81K $1.29 $2.34K
Apr 04, 2023 Bryan Giraudo N/A Purchase 55.00K $1.02 $56.10K
Mar 22, 2023 Faheem Hasnain N/A Purchase 440.50K $1.14 $502.17K
Mar 20, 2023 Bryan Giraudo N/A Purchase 50.00K $0.97 $48.50K
Mar 20, 2023 Faheem Hasnain N/A Purchase 168.68K $1.03 $173.74K
Mar 20, 2023 Waage Christian N/A Purchase 18.50K $1.20 $22.20K
Mar 16, 2023 Caryn Peterson N/A Sale 7.56K $1.10 $8.32K
Mar 16, 2023 Laura Carter N/A Sale 6.03K $1.10 $6.63K

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about GOSS.US!